Seshu Tyagarajan, Chief Technology Officer at Candel Therapeutics, Inc. (CADL), sold 29,702 shares at $6.47 ($192K) on 2024-07-17, disclosed to the SEC on 2024-07-19.
Open-market sale of $192k CADL by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.47 | 14,851 | $96K | 50.0% |
| 2 | $6.47 | 14,851 | $96K | 50.0% |
| Total | $6.47 avg | 29,702 | $192K | 100% |
| Filing → |
| CADL | SELL | 2025-03-20 | $552K | — | Filing → |
| CADL | SELL | 2025-01-17 | $207K | — | Filing → |
| CADL | SELL | 2025-01-10 | $239K | — | Filing → |